Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satshil Rana

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
NPJ Precision Oncology|July 28, 2024
Pathologic complete response to KEYNOTE522 and HER2-directed therapy for synchronous TNBC and HER2+ breast cancerNicholas Mai, Jie-Fu Chen, Satshil Rana, et al.
Journal of Cutaneous Pathology|February 24, 2021
Primary cutaneous SMARCB1-deficient carcinomaYiang Hui, Paolo Cotzia, Satshil Rana, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 25, 2023
Loss of CDKN2A/B is a Molecular Marker of High-grade Histology and is Associated with Aggressive Behavior in Acinic Cell CarcinomaSnjezana Dogan, Bin Xu, Satshil Rana, et al.
Gynecologic Oncology|September 14, 2024
Concurrent POLE hotspot mutations and mismatch repair deficiency/microsatellite instability in endometrial cancer: A challenge in molecular classificationSara Moufarrij, Andrea Gazzo, Satshil Rana, et al.
Human Pathology|June 30, 2020
E-cadherin immunohistochemical expression in invasive lobular carcinoma of the breast: correlation with morphology and CDH1 somatic alterationsAnne Grabenstetter, Abhinita S Mohanty, Satshil Rana, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 21, 2019
Retained mismatch repair protein expression occurs in approximately 6% of microsatellite instability-high cancers and is associated with missense mutations in mismatch repair genesJaclyn F Hechtman, Satshil Rana, Sumit Middha, et al.
NPJ Precision Oncology|August 7, 2025
Genomic characterization of tumor mutational burden-high breast carcinomasTheodore Vougiouklakis, Chad Vanderbilt, Satshil Rana, et al.
Neuro-Oncology Advances|June 22, 2023
Leptomeningeal disease in histone-mutant gliomasMaria Diaz, Satshil Rana, Carlos Eduardo Silva Correia, et al.
Head and Neck Pathology|June 17, 2024
DNA Mutational and Copy Number Variation Profiling of Primary Craniofacial Osteosarcomas by Next-Generation SequencingGord Guo Zhu, Chuanyong Lu, Ivana Petrovic, et al.
JCO Precision Oncology|April 23, 2019
Majority of <i>B2M</i>-Mutant and -Deficient Colorectal Carcinomas Achieve Clinical Benefit From Immune Checkpoint Inhibitor Therapy and Are Microsatellite Instability-HighSumit Middha, Rona Yaeger, Jinru Shia, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
NPJ Precision Oncology|July 28, 2024
Pathologic complete response to KEYNOTE522 and HER2-directed therapy for synchronous TNBC and HER2+ breast cancerNicholas Mai, Jie-Fu Chen, Satshil Rana, et al.
Journal of Cutaneous Pathology|February 24, 2021
Primary cutaneous SMARCB1-deficient carcinomaYiang Hui, Paolo Cotzia, Satshil Rana, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 25, 2023
Loss of CDKN2A/B is a Molecular Marker of High-grade Histology and is Associated with Aggressive Behavior in Acinic Cell CarcinomaSnjezana Dogan, Bin Xu, Satshil Rana, et al.
Gynecologic Oncology|September 14, 2024
Concurrent POLE hotspot mutations and mismatch repair deficiency/microsatellite instability in endometrial cancer: A challenge in molecular classificationSara Moufarrij, Andrea Gazzo, Satshil Rana, et al.
Human Pathology|June 30, 2020
E-cadherin immunohistochemical expression in invasive lobular carcinoma of the breast: correlation with morphology and CDH1 somatic alterationsAnne Grabenstetter, Abhinita S Mohanty, Satshil Rana, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 21, 2019
Retained mismatch repair protein expression occurs in approximately 6% of microsatellite instability-high cancers and is associated with missense mutations in mismatch repair genesJaclyn F Hechtman, Satshil Rana, Sumit Middha, et al.
NPJ Precision Oncology|August 7, 2025
Genomic characterization of tumor mutational burden-high breast carcinomasTheodore Vougiouklakis, Chad Vanderbilt, Satshil Rana, et al.
Neuro-Oncology Advances|June 22, 2023
Leptomeningeal disease in histone-mutant gliomasMaria Diaz, Satshil Rana, Carlos Eduardo Silva Correia, et al.
Head and Neck Pathology|June 17, 2024
DNA Mutational and Copy Number Variation Profiling of Primary Craniofacial Osteosarcomas by Next-Generation SequencingGord Guo Zhu, Chuanyong Lu, Ivana Petrovic, et al.
JCO Precision Oncology|April 23, 2019
Majority of <i>B2M</i>-Mutant and -Deficient Colorectal Carcinomas Achieve Clinical Benefit From Immune Checkpoint Inhibitor Therapy and Are Microsatellite Instability-HighSumit Middha, Rona Yaeger, Jinru Shia, et al.
Pageof 3